Top

Published in:

05-02-2024 | Obesity | ORIGINAL ARTICLE

Association between anthropometric indices and hyperuricemia: a nationwide study in China

Authors: Deshi Chen, Cihang Lu, Kang Chen, Tingting Liu, Yongze Li, Zhongyan Shan, Weiping Teng, the Thyroid disorders, Iodine status and Diabetes Epidemiological Survey Group (TIDE)

Published in: Clinical Rheumatology | Issue 3/2024

Abstract

This article explored the relationship between anthropometric indices and hyperuricemia in Chinese adults. The ability of each anthropometric index to predict hyperuricemia was also compared in this article. This is a cross-sectional study containing 69,842 samples from 31 provinces and cities in China. Anthropometric indices included body mass index (BMI), waist circumference (WC), a body shape index (ABSI), body roundness index (BRI), waist-to-height ratio (WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride-glucose index (TyG), waist circumference-triglyceride index (WTI), and weight-adjusted waist index (WWI). The survey data obtained were disaggregated and analyzed according to sex and age. BMI, WC, BRI, WHtR, LAP, VAI, TyG, WTI, and WWI were all significantly associated with hyperuricemia (P < 0.001). In the total population, WTI (AUC 0.7015, P < 0.001) had the highest predictive power, and WWI (AUC 0.5417, P < 0.001) had the lowest. In addition, after dividing the male and female populations, LAP (AUC 0.6571, P < 0.001 for men; AUC 0.7326, P < 0.001 for women) had the highest predictive power among both men and women. The ABSI (AUC 0.5189, P < 0.001 for men; AUC 0.5788, P < 0.001 for women) had the lowest predictive power among both men and women. BMI, WC, BRI, WHtR, LAP, VAI, TyG, and WTI were positively correlated with the risk of hyperuricemia and serum uric acid concentrations in both sexes. Among the general population, WTI had the highest predictive power. After dividing the population by sex, LAP had the highest predictive power in both men and women.

Key Points

• Anthropometric indices are highly correlated with hyperuricemia. Waist circumference-triglyceride index (WTI) is first found to be associated with hyperuricemia, and it has high predictive power.

• The predictive power of anthropometric indices for hyperuricemia is more useful in women.

• The restricted cubic splines visually shows the ratio of anthropometric indices to hyperuricemia ratio and the patient’s serum uric acid concentration.

So A, Thorens B (2010) Uric acid transport and disease. J Clin Invest 120(6):1791–1799. https://doi.org/10.1172/JCI42344CrossRefPubMedPubMedCentral

Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16(7):380–390. https://doi.org/10.1038/s41584-020-0441-1CrossRefPubMed

Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, Merriman TR, Moe OW, Mount DB, Sanchez Lozada LG, Stahl E, Weiner DE, Chertow GM (2018) Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis 71(6):851–865. https://doi.org/10.1053/j.ajkd.2017.12.009CrossRefPubMedPubMedCentral

Joosten LAB, Crisan TO, Bjornstad P, Johnson RJ (2020) Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol 16(2):75–86. https://doi.org/10.1038/s41584-019-0334-3CrossRefPubMed

Zhang M, Zhu X, Wu J, Huang Z, Zhao Z, Zhang X, Xue Y, Wan W, Li C, Zhang W, Wang L, Zhou M, Zou H, Wang L (2021) Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19. Front Immunol 12:791983. https://doi.org/10.3389/fimmu.2021.791983CrossRefPubMed

Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK (2019) Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol 71(6):991–999. https://doi.org/10.1002/art.40807CrossRefPubMedPubMedCentral

N M, Id O, C Y, Id O, N L, AD J, GC C, HK C (2022) Impact of adiposity on risk of female gout among those genetically predisposed. Ann Rheum Dis 81 (4):556-563

Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, Shirakura T, Kato K, Imaizumi K, Takahashi H, Tamura M, Maeda N, Funahashi T, Shimomura I (2013) Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 288(38):27138–27149. https://doi.org/10.1074/jbc.M113.485094CrossRefPubMedPubMedCentral

Maglio C, Peltonen M, Neovius M, Jacobson P, Jacobsson L, Rudin A, Carlsson LM (2017) Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis 76(4):688–693. https://doi.org/10.1136/annrheumdis-2016-209958CrossRefPubMed

10.

Zhang N, Chang Y, Guo X, Chen Y, Ye N, Sun Y (2016) A Body Shape Index and Body Roundness Index: two new body indices for detecting association between obesity and hyperuricemia in rural area of China. Eur J Intern Med 29:32–36. https://doi.org/10.1016/j.ejim.2016.01.019CrossRefPubMed

11.

Liu XZ, Li HH, Huang S, Zhao DB (2019) Association between hyperuricemia and nontraditional adiposity indices. Clin Rheumatol 38(4):1055–1062. https://doi.org/10.1007/s10067-018-4374-xCrossRefPubMed

12.

Li Y, Teng D, Ba J, Chen B, Du J, He L, Lai X, Teng X, Shi X, Li Y, Chi H, Liao E, Liu C, Liu L, Qin G, Qin Y, Quan H, Shi B, Sun H, Tang X, Tong N, Wang G, Zhang JA, Wang Y, Xue Y, Yan L, Yang J, Yang L, Yao Y, Ye Z, Zhang Q, Zhang L, Zhu J, Zhu M, Ning G, Mu Y, Zhao J, Shan Z, Teng W (2020) Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of Mainland China. Thyroid 30(4):568–579. https://doi.org/10.1089/thy.2019.0067CrossRefPubMed

13.

Sun Y, Teng D, Zhao L, Shi X, Li Y, Shan Z, Teng W (2022) Impaired sensitivity to thyroid hormones is associated with hyperuricemia, obesity, and cardiovascular disease risk in subjects with subclinical hypothyroidism. Thyroid 32(4):376–384. https://doi.org/10.1089/thy.2021.0500CrossRefPubMed

14.

Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16(4):223–237. https://doi.org/10.1038/s41581-019-0244-2CrossRefPubMedPubMedCentral

15.

American Diabetes A (2015) (2) Classification and diagnosis of diabetes. Diabetes Care 38(Suppl):S8–S16. https://doi.org/10.2337/dc15-S005CrossRef

16.

Piao W, Zhao L, Yang Y, Fang H, Ju L, Cai S, Yu D (2022) The prevalence of hyperuricemia and its correlates among adults in China: results from CNHS 2015–2017. Nutrients 14(19) https://doi.org/10.3390/nu14194095

17.

Tang J, Zhao S, Yu S, Chi C, Ji H, Xiong J, Teliewubai J, Fan X, Maimaitiaili R, Xu Y, Zhang Y (2021) Association between hypertension-mediated organ damage and obesity defined by novel anthropometric indices in community-dwelling elderly individuals. Clin Nutr 40(6):4473–4480. https://doi.org/10.1016/j.clnu.2020.12.035CrossRefPubMed

18.

Ahn N, Baumeister SE, Amann U, Rathmann W, Peters A, Huth C, Thorand B, Meisinger C (2019) Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Sci Rep 9(1):9693. https://doi.org/10.1038/s41598-019-46187-8ADSCrossRefPubMedPubMedCentral

19.

Ding X, Wang X, Wu J, Zhang M, Cui M (2021) Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol 20(1):76. https://doi.org/10.1186/s12933-021-01268-9CrossRefPubMedPubMedCentral

20.

Ma CM, Lu N, Wang R, Liu XL, Lu Q, Yin FZ (2017) Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes. Sci Rep 7(1):9843. https://doi.org/10.1038/s41598-017-10446-3ADSCrossRefPubMedPubMedCentral

21.

Kim NH, Park Y, Kim NH, Kim SG (2021) Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults. Age Ageing 50(3):780–786. https://doi.org/10.1093/ageing/afaa208CrossRefPubMed

22.

Smith AD, Crippa A, Woodcock J, Brage S (2016) Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetologia 59(12):2527–2545. https://doi.org/10.1007/s00125-016-4079-0CrossRefPubMedPubMedCentral

23.

Kuwabara M, Kuwabara R, Niwa K, Hisatome I, Smits G, Roncal-Jimenez CA, MacLean PS, Yracheta JM, Ohno M, Lanaspa MA, Johnson RJ, Jalal DI (2018) Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects. Nutrients 10(8) https://doi.org/10.3390/nu10081011

24.

Song P, Wang H, Xia W, Chang X, Wang M, An L (2018) Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep 8(1):4314. https://doi.org/10.1038/s41598-018-22570-9ADSCrossRefPubMedPubMedCentral

25.

Muller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A (2012) Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev 13(Suppl 2):6–13. https://doi.org/10.1111/j.1467-789X.2012.01033.xCrossRefPubMed

26.

Dong J, Ni YQ, Chu X, Liu YQ, Liu GX, Zhao J, Yang YB, Yan YX (2016) Association between the abdominal obesity anthropometric indicators and metabolic disorders in a Chinese population. Public Health 131:3–10. https://doi.org/10.1016/j.puhe.2015.08.001CrossRefPubMed

27.

Shirasawa T, Ochiai H, Yoshimoto T, Nagahama S, Watanabe A, Yoshida R, Kokaze A (2020) Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord 20(1):2. https://doi.org/10.1186/s12902-019-0481-1CrossRefPubMedPubMedCentral

28.

Nevill AM, Stewart AD, Olds T, Duncan MJ (2020) A new waist-to-height ratio predicts abdominal adiposity in adults. Res Sports Med 28(1):15–26. https://doi.org/10.1080/15438627.2018.1502183CrossRefPubMed

29.

Zhou Z, Li K, Li X, Luan R, Zhou R (2021) Independent and joint associations of body mass index, waist circumference, waist-height ratio and their changes with risks of hyperuricemia in middle-aged and older Chinese individuals: a population-based nationwide cohort study. Nutr Metab (Lond) 18(1):62. https://doi.org/10.1186/s12986-021-00590-zCrossRefPubMed

30.

Huang ZP, Huang BX, Zhang H, Zhu MF, Zhu HL (2019) Waist-to-height ratio is a better predictor of hyperuricemia than body mass index and waist circumference in Chinese. Ann Nutr Metab 75(3):187–194. https://doi.org/10.1159/000504282CrossRefPubMed

31.

Kim TH, Lee SS, Yoo JH, Kim SR, Yoo SJ, Song HC, Kim YS, Choi EJ, Kim YK (2012) The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr 4(1):3. https://doi.org/10.1186/1758-5996-4-3CrossRefPubMedPubMedCentral

32.

Rospleszcz S, Dermyshi D, Muller-Peltzer K, Strauch K, Bamberg F, Peters A (2020) Association of serum uric acid with visceral, subcutaneous and hepatic fat quantified by magnetic resonance imaging. Sci Rep 10(1):442. https://doi.org/10.1038/s41598-020-57459-zADSCrossRefPubMedPubMedCentral

33.

Hou YL, Yang XL, Wang CX, Zhi LX, Yang MJ, You CG (2019) Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents. Lipids Health Dis 18(1):81. https://doi.org/10.1186/s12944-019-1031-6CrossRefPubMedPubMedCentral

34.

Zhou S, Yu Y, Zhang Z, Ma L, Wang C, Yang M, Cheng X, Liu T, Sun R, Chen Y (2022) Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao. China Front Endocrinol (Lausanne) 13:1001844. https://doi.org/10.3389/fendo.2022.1001844CrossRefPubMedPubMedCentral

35.

Yu X, Wang D, Xiao W, Shi X, She Q, Sun H, Qi T, Xu R, Li G, Liu X, Gong W, Yan Z, Ding Y, Lu G (2020) Relationship between fatty pancreas and hypertriglyceridemic waist phenotype: a cross-sectional study. Sci Rep 10(1):21937. https://doi.org/10.1038/s41598-020-78883-1ADSCrossRefPubMedPubMedCentral

36.

Dong H, Xu Y, Zhang X, Tian S (2017) Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes. Sci Rep 7(1):8822. https://doi.org/10.1038/s41598-017-09455-zADSCrossRefPubMedPubMedCentral

37.

Huang X, Jiang X, Wang L, Chen L, Wu Y, Gao P, Hua F (2019) Visceral adipose accumulation increased the risk of hyperuricemia among middle-aged and elderly adults: a population-based study. J Transl Med 17(1):341. https://doi.org/10.1186/s12967-019-2074-1CrossRefPubMedPubMedCentral

38.

Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O (2012) Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 176(2):108–116. https://doi.org/10.1093/aje/kws002CrossRefPubMed

39.

Han T, Lan L, Qu R, Xu Q, Jiang R, Na L, Sun C (2017) Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension 70(4):703–711. https://doi.org/10.1161/HYPERTENSIONAHA.117.09508CrossRefPubMed

40.

Sun H, Chang X, Bian N, An Y, Liu J, Leng S, Wang G (2022) Adipose tissue insulin resistance is positively associated with serum uric acid levels and hyperuricemia in Northern Chinese adults. Front Endocrinol (Lausanne) 13:835154. https://doi.org/10.3389/fendo.2022.835154CrossRefPubMed

41.

Liu XZ, Xu X, Zhu JQ, Zhao DB (2019) Association between three non-insulin-based indexes of insulin resistance and hyperuricemia. Clin Rheumatol 38(11):3227–3233. https://doi.org/10.1007/s10067-019-04671-6CrossRefPubMed

42.

Mazidi M, Katsiki N, Mikhailidis DP, Banach M (2018) The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis 270:180–186. https://doi.org/10.1016/j.atherosclerosis.2017.12.033CrossRefPubMed

43.

McCormick N, O’Connor MJ, Yokose C, Merriman TR, Mount DB, Leong A, Choi HK (2021) Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional Mendelian randomization. Arthritis Rheumatol 73(11):2096–2104. https://doi.org/10.1002/art.41779CrossRefPubMedPubMedCentral

44.

Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, Zheng L (2021) Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig 12(11):2046–2053. https://doi.org/10.1111/jdi.13573CrossRefPubMedPubMedCentral

45.

Yokose C, McCormick N, Choi HK (2021) The role of diet in hyperuricemia and gout. Curr Opin Rheumatol 33(2):135–144. https://doi.org/10.1097/BOR.0000000000000779CrossRefPubMedPubMedCentral

Title: Association between anthropometric indices and hyperuricemia: a nationwide study in China
Authors: Deshi Chen
Cihang Lu
Kang Chen
Tingting Liu
Yongze Li
Zhongyan Shan
Weiping Teng
the Thyroid disorders, Iodine status and Diabetes Epidemiological Survey Group (TIDE)
Publication date: 05-02-2024
Publisher: Springer International Publishing
Keywords: Obesity
Obesity
Published in: Clinical Rheumatology / Issue 3/2024
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-024-06884-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2024

Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus

Intrathecal injection of methotrexate and dexamethasone for vasculitis granuloma of the fourth ventricle: a case report and literature review

Fatty infiltration in the posterior muscles of the lower extremities as an MRI feature in antimitochondrial antibody–associated myopathy

Cumulative pulse methylprednisolone and its relation to disease activity, damage and mortality in systemic lupus erythematosus patients: A post hoc analysis of COMOSLE-EGYPT study

Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials